Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (NCT07832032) titled 'Biological Profiles of Neuropeptides, Neurotrophins and miRNA in Migraine' on Sept. 11.
Study Type: Observational
Primary Sponsor: Nordlandssykehuset HF
Condition:
Migraine
Intervention:
Drug: Rimegepant 75 MG
Recruitment Status: Not recruiting
Date of First Enrollment: September 17, 2026
Target Sample Size: 60
Countries of Recruitment:
Norway
To know more, visit https://clinicaltrials.gov/study/NCT07832032
Disclaimer: Curated by HT Syndication....